1. Home
  2. DDS vs KRYS Comparison

DDS vs KRYS Comparison

Compare DDS & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dillard's Inc.

DDS

Dillard's Inc.

HOLD

Current Price

$516.08

Market Cap

9.5B

ML Signal

HOLD

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$374.69

Market Cap

10.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDS
KRYS
Founded
1938
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
10.3B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
DDS
KRYS
Price
$516.08
$374.69
Analyst Decision
Sell
Strong Buy
Analyst Count
3
11
Target Price
$519.67
$297.60
AVG Volume (30 Days)
95.5K
343.1K
Earning Date
05-14-2026
05-04-2026
Dividend Yield
5.55%
N/A
EPS Growth
N/A
128.00
EPS
N/A
1.83
Revenue
N/A
$389,130,000.00
Revenue This Year
$0.99
$38.74
Revenue Next Year
$1.09
$32.53
P/E Ratio
$18.08
$204.96
Revenue Growth
N/A
33.94
52 Week Low
$424.87
$130.50
52 Week High
$741.98
$382.54

Technical Indicators

Market Signals
Indicator
DDS
KRYS
Relative Strength Index (RSI) 37.25 73.60
Support Level $518.05 $244.43
Resistance Level $593.14 N/A
Average True Range (ATR) 22.23 13.30
MACD -5.65 2.48
Stochastic Oscillator 3.38 88.14

Price Performance

Historical Comparison
DDS
KRYS

About DDS Dillard's Inc.

Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.

Share on Social Networks: